Summary
Matyas Szigeti is Clinical Trial Statistician at Imperial Clinical Trials Unit at Imperial College London since 2014. He has experience evaluating drug and surgical interventions across a broad range of therapeutic areas including asthma and pulmonary diseases, cardiovascular diseases, hepatitis and in vitro fertilisation. His statistical research interests are extreme value statistics, generalisability of clinical trial results and missing data imputation. He provided expert reviews for research proposals of the NIHR HTA Programme.
Current studies include: RECITAL, NUC-B, MICAH and C-19-ACS whilst past studies include Y14, EVRA, Rituxilup, HARMONY, Kisspeptin and AZALEA.
The AZALEA trial paper won the BMJ Research paper of the year award in 2017.
He obtained a BSc in Military and Safety Engineering in 2010 from Obuda University, Hungary and an MSc in Biomedical Engineering from Budapest University of Technology and Economics in 2012 and an MSc in Medical Statistics from University of Leicester in 2014.
Publications
Journals
Maher TM, Tudor VA, Saunders P, et al. , 2024, Rituximab compared to intravenous cyclophosphamide in adults with connective tissue disease-associated interstitial lung disease: the RECITAL RCT, Efficacy and Mechanism Evaluation, ISSN:2050-4365, Pages:1-68
Nagy Z, Kiss N, Szigeti M, et al. , 2024, Construct validity of the Hungarian Version of the Patient-Reported Outcomes Measurement Information System-29 Profile Among Patients with Low Back Pain., World Neurosurg, Vol:181, Pages:e55-e66
Merkely B, Hatala R, Wranicz JK, et al. , 2023, Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial., Eur Heart J, Vol:44, Pages:4259-4269
Kanagaratnam P, Francis DP, Chamie D, et al. , 2023, A randomised controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalised with COVID-19: the C19-ACS trial, Journal of Thrombosis and Haemostasis, Vol:21, ISSN:1538-7836, Pages:2213-2222
Zadori A, Kis Z, Toth T, et al. , 2023, Long-Term Efficacy and Safety of Left Atrial Appendage Closure Procedures., Int Heart J, Vol:64, Pages:188-195